Zobrazeno 41 - 50
of 1 394
pro vyhledávání: ''
Autor:
Anna K. Dewan, Brian C. Drolet, Danny Zakria, Sharon E. Albers, Lee Wheless, James R. Patrinely, Aleta N Simmons
Publikováno v:
Journal of Dermatological Treatment. 33:2034-2037
Background Corticosteroid injections are a commonly used treatment for dermatologic pathologies. Although the injectable is often prepared with a local anesthetic, we hypothesize that patients receiving an injection with anesthetic will experience no
Autor:
Claudia Giraldo-Giraldo, Diego Alejandro Medina-Morales, Luis Fernando Valladales-Restrepo, Jorge Enrique Machado-Alba
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 17:627-634
Background: Statins have extensive hepatic metabolism and can have multiple pharmacological interactions. The aim was to identify the main pharmacokinetic interactions between statins and their comedications in a group of patients from Colombia.Resea
Publikováno v:
Drug Development and Industrial Pharmacy. 47:626-635
Colistin sulfate is a very important antibiotic for the treatment of multidrug-resistant Gram-negative infections. Unfortunately, it has low oral bioavailability and several side effects following parenteral administration. The present study aims to
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Kengo Tokunaga 1Chihiro Suzuki 2Miyuki Hasegawa 2Ikuo Fujimori 21Department of General Medicine,Kyorin University School of Medicine,Tokyo, Japan; 2Japan Medical Office,Takeda Pharmaceutical Company Limited,Tokyo, Japan Correspondence: Kengo Tokunaga
Autor:
Guenter Froeschl, Tsegaye Melaku, Arne Kroidl, Esayas Kebede Gudina, Melkamu Berhane, Solomon Ali, Legese Chelkeba, Andreas Wieser, Getnet Tesfaw, Tekle Wakjira, Gemechu Lemi, Zeleke Mekonnen, Sisay Bekele, Mulatu Gashaw
Publikováno v:
Infection and Drug Resistance
Tsegaye Melaku,1 Mulatu Gashaw,2 Legese Chelkeba,3 Melkamu Berhane,4 Sisay Bekele,5 Gemechu Lemi,6 Tekle Wakjira,7 Getnet Tesfaw,2 Zeleke Mekonnen,2 Solomon Ali,8 Arne Kroidl,9,10 Andreas Wieser,9,10 Guenter Froeschl,9,10 Esayas Kebede Gudina11 1Scho
Publikováno v:
Infection and Drug Resistance
Alice Kit Ying Chan, Yiu Cheung Tsang, Chun Hung Chu, Chiu Shun Peter Tsang Faculty of Dentistry, University of Hong Kong, Prince Philip Dental Hospital, Hong Kong Special Administrative Region of the People’s Republic of ChinaCorrespondence: Chiu
Publikováno v:
Journal of Pain Research
The interest in substances that stimulate respiration has waxed and waned throughout the years, intensifying following the introduction of a new class of drugs that causes respiratory depression, and diminishing when antidotes or better drug alternat
Publikováno v:
Journal of Pain Research
Chunmei Zhao,1 Shaoheng Wang,1 Yuesong Pan,2,3 Nan Ji,4 Fang Luo1 1Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China; 2Department of Neurology, Beijing Tiantan Hospital,
Publikováno v:
Vascular Health and Risk Management
Daiji Nagayama,1,2 Atsuhito Saiki,2 Kohji Shirai3 1Department of Internal Medicine, Nagayama Clinic, Tochigi, Japan; 2Center of Diabetes, Endocrine and Metabolism, Toho University Sakura Medical Center, Chiba, Japan; 3Department of Internal Medicine,
Autor:
Charlotte Soderman, Mark Clements, Pär Myrelid, Agnieszka Wagner, David Andersson, Hans Strid, Anders Forss, Fredrik Hjelm, Jonas F. Ludvigsson, Jonas Halfvarson, Ola Olén
Publikováno v:
Scandinavian Journal of Gastroenterology. 56:680-686
Background Prospectively and systematically collected real-world data on the effectiveness of ustekinumab (anti-interleukin-12/23) for treating Crohns disease (CD) are still limited. Aim To assess the short-term real-world effectiveness of ustekinuma